MIND MEDICINE MINDMED INC (MNMD) Stock News

MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

Why Mind Medicine Stock Is Skyrocketing Today

Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months

Kennedy has previously advocated for decriminalizing psychedelics for therapeutic use, citing his son’s positive experience with the hallucinogenic brew ayahuasca.

Mentions: ATAI CMPS

RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.

The Senate will vote Thursday on whether to put RFK Jr. in charge of health. It's unclear how he will impact biotech stocks.

Mentions: PCVX MRNA CYBN CMPS

Why Mind Medicine Stock Is Soaring Today

MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder

Mind Medicine Stock Rises As Evercore Projects 200% Upside On LSD Formulation: Retail Turns Bullish

The brokerage also pointed to potential large-scale expansion opportunities and emphasized the growing acceptance of psychedelics in future treatment paradigms.

Mentions: PSIL XPH IWC

This Westlake Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Mentions: ALB SKT WLK EXE

MindMed to Be Added to the Nasdaq Biotechnology Index

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)

MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress

MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)

MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy

MindMed Announces New Employee Inducement Grants

MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer

AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?

AI and psychedelic medicine are merging, with research showing AI's role in drug discovery, trials, and personalized mental health care.

Mentions: ATAI CMPS

MindMed to Participate in Upcoming Investor Conferences

MindMed Reports Third Quarter 2024 Financial Results and Business Updates

MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update

MindMed Announces New Employee Inducement Grants

MindMed to Participate in September Investor Conferences